Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
Vor Bio (Nasdaq: VOR) will present a corporate update in a fireside chat at the Jefferies Global Healthcare Conference in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vor Bio (Nasdaq: VOR) will present a corporate update in a fireside chat at the Jefferies Global Healthcare Conference in New York.
The presentation is scheduled for Wednesday, June 3, 2026, from 9:55–10:25 a.m. ET, with a live webcast and 30-day replay on the Vor Bio investor website.
Details
News Market Reaction – VOR
On May 28, the day this news came out, VOR closed 3.29% below the previous close.
Data tracked by StockTitan Argus for the May 28 session.
Key Figures
- Conference date
- June 3, 2026
- Jefferies Global Healthcare Conference presentation date
- Presentation time
- 9:55am–10:25am ET
- Jefferies conference fireside chat slot
- Webcast replay period
- 30 days
- Replay available on Vor website after presentation
Historical Context
-
Interim Phase 3 TELIGAN data in IgA nephropathy published in NEJM.
-
Q1 2026 results and corporate update with cash runway into early 2029.
-
Inducement stock options and RSUs granted to six new employees.
-
Additional inducement options and RSUs granted to new hires.
-
Q4 and 2025 results plus a $75M private placement and cash update.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
autoimmune diseases medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will provide a corporate update in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY.
Presentation: Wednesday, June 3, 2026 at 9:55am – 10:25 am ET
A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation.
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.
Media & Investor Contacts: Carl Mauch cmauch@vorbio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.